Skip to content

All Research Preprints

221-240 of 579 ARTICLES
https://doi.org/10.12688/verixiv.888.2
Research Article metrics
Revised
Potential for Family Planning Program Sustainability Across 33 Countries in Two Regions of sub-Saharan Africa
[version 2; peer review: 2 approved]
Peer Reviewers John Cleland; Akanni Ibukun Akinyemi
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 31 Oct 2025
https://doi.org/10.12688/verixiv.1964.1
Research Article metrics
Development of High-Concentration Long-Acting Injectable Formulations of TBAJ-587 and TBAJ-876 as an Extended Treatment Strategy Against Tuberculosis
[version 1]
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 28 Oct 2025
https://doi.org/10.12688/verixiv.1847.2
Research Article metrics AWAITING PEER REVIEW
Revised
Community Perceptions of incentives for minimally invasive autopsy in Child Health and Mortality Prevention Surveillance (CHAMPS) in Western Kenya: A qualitative study
[version 2; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 28 Oct 2025
https://doi.org/10.12688/verixiv.2269.1
Research Article metrics
Gender Responsive Technology Assessment Index: Scaling Inclusive Climate Smart Interventions in Data-Limited Settings
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 28 Oct 2025
https://doi.org/10.12688/verixiv.2259.1
Research Article metrics
Genetic Diversity of Plasmodium falciparum helical interspersed subtelomeric (phistb) gene in Tanzania and neighboring countries
[version 1]
Peer Reviewers Invited
  • Funders
  • Bill and Melinda Gates Foundation
  • Gates Foundation
PUBLISHED 28 Oct 2025
https://doi.org/10.12688/verixiv.1966.2
Research Article metrics
Revised
Cost-effectiveness of Tranexamic Acid for Women Giving Birth: Evidence from Five Major Clinical Trials
[version 2; peer review: 1 approved with reservations]
Peer Reviewers Antonio Ragusa
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 27 Oct 2025
https://doi.org/10.12688/verixiv.970.2
Research Article metrics
Revised
How has the private sector for antimalarials and malaria testing changed in Benin? Trends from the ACTwatch Lite market study 2016 to 2023
[version 2; peer review: 1 approved]
Peer Reviewers Innocent Ali Mbulli
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 27 Oct 2025
https://doi.org/10.12688/verixiv.2273.1
Research Article metrics
Evaluating the Validity of Adherence Measurement Methods for Multiple Micronutrient Supplementations (MMS) among Pregnant Women in Ethiopia: Comparing Self-Reports and Pill Counts
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 27 Oct 2025
https://doi.org/10.12688/verixiv.2268.1
Research Article metrics
Does Women’s Political Participation Result in Change? A Global Analysis of Gender Empowerment Metrics
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.2206.1
Research Article metrics
Exposure to social and behavior change interventions directly and indirectly improved health and nutrition-related awareness, knowledge, and practices among male household heads and grandmothers in Nepal
[version 1]
Peer Reviewers Invited
  • Funders
  • UK Aid from the UK government
  • Gates Foundation
PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.2144.1
Research Article metrics
Barriers and Enablers: Exploring Vaccine Uptake Among Middle-Aged and Older Adults in a Multi-Ethnic Region of China
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.2260.1
Systematic Review metrics
Impact of Moringa oleifera intake during pregnancy and lactation on maternal and child health outcomes - A systematic review
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.1789.2
Research Article metrics
Revised
Physiological Maturity Determination of Wild Banana (Musa acuminata subsp. malaccensis (Ridl.) N.W.Simmonds) for Seed Conservation
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Anbarasu Mariyappillai; Khaled FM Salem; Iffah Hazirah Mohd Nawi
  • Funders
  • RIIM Batch 2 under LPDP and Deputy of Research and Innovation Facilitation BRIN
  • Gates Foundation
LATEST VERSION PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.1323.2
Research Article metrics
Revised
CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program
[version 2; peer review: 2 approved]
Peer Reviewers Khuthala Mnika; Miguel Brito
  • Funder
  • Gates Foundation
LATEST VERSION PUBLISHED 24 Oct 2025
https://doi.org/10.12688/verixiv.2198.1
Study Protocol metrics AWAITING PEER REVIEW
Human Leukocyte Antigen Diversity and High-Risk HPV Outcomes in Adolescent Girls in Kenya: A Laboratory-Based Protocol
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 23 Oct 2025
https://doi.org/10.12688/verixiv.2055.1
Systematic Review metrics
Climate health competencies for the health workforce in low-middle income countries – A scoping review
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 21 Oct 2025
https://doi.org/10.12688/verixiv.2246.1
Research Article metrics
Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe
[version 1]
Peer Reviewers Invited
  • Funders
  • Gates Foundation
  • American Association for Cancer Research
PUBLISHED 20 Oct 2025
https://doi.org/10.12688/verixiv.2078.1
Research Article metrics
Enhancing the Implementation of Kenya’s AGPO Program: Insights from Implementing Agencies
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 20 Oct 2025
https://doi.org/10.12688/verixiv.1155.2
Research Article metrics
Revised
Prevalence of Molecular Markers of Resistance to Antimalarial Drugs Three Years After Perennial Malaria Chemoprevention in Sierra Leone
[version 2; peer review: 2 approved]
Peer Reviewers Thiery Masserey; Romain Coppée
  • Funders
  • Departament d’Universitats i Recerca de la Generalitat de Catalunya
  • Gates Foundation
LATEST VERSION PUBLISHED 20 Oct 2025
https://doi.org/10.12688/verixiv.2223.1
Research Article metrics
Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use
[version 1]
Peer Reviewers Invited
  • Funder
  • Gates Foundation
PUBLISHED 16 Oct 2025
221-240 of 579 ARTICLES

Stay Informed

Sign up for information about developments, publishing and publications from VeriXiv.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to VeriXiv

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.